Galera Therapeutics (GRTX) Competitors $0.04 0.00 (-7.16%) As of 12:37 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends GRTX vs. KPRX, BCDA, PHIO, TLPH, INDP, CDT, ENSC, MYNZ, SPRC, and BFRIShould you be buying Galera Therapeutics stock or one of its competitors? The main competitors of Galera Therapeutics include Kiora Pharmaceuticals (KPRX), BioCardia (BCDA), Phio Pharmaceuticals (PHIO), Talphera (TLPH), Indaptus Therapeutics (INDP), Conduit Pharmaceuticals (CDT), Ensysce Biosciences (ENSC), Mainz Biomed (MYNZ), SciSparc (SPRC), and Biofrontera (BFRI). These companies are all part of the "pharmaceutical products" industry. Galera Therapeutics vs. Kiora Pharmaceuticals BioCardia Phio Pharmaceuticals Talphera Indaptus Therapeutics Conduit Pharmaceuticals Ensysce Biosciences Mainz Biomed SciSparc Biofrontera Galera Therapeutics (NASDAQ:GRTX) and Kiora Pharmaceuticals (NASDAQ:KPRX) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their community ranking, dividends, analyst recommendations, risk, earnings, profitability, institutional ownership, media sentiment and valuation. Does the MarketBeat Community prefer GRTX or KPRX? Galera Therapeutics received 33 more outperform votes than Kiora Pharmaceuticals when rated by MarketBeat users. However, 73.91% of users gave Kiora Pharmaceuticals an outperform vote while only 54.35% of users gave Galera Therapeutics an outperform vote. CompanyUnderperformOutperformGalera TherapeuticsOutperform Votes5054.35% Underperform Votes4245.65% Kiora PharmaceuticalsOutperform Votes1773.91% Underperform Votes626.09% Which has stronger valuation & earnings, GRTX or KPRX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGalera TherapeuticsN/AN/A-$59.08M-$0.35-0.13Kiora PharmaceuticalsN/AN/A-$12.51MN/AN/A Do institutionals and insiders believe in GRTX or KPRX? 50.8% of Galera Therapeutics shares are held by institutional investors. Comparatively, 77.0% of Kiora Pharmaceuticals shares are held by institutional investors. 6.9% of Galera Therapeutics shares are held by insiders. Comparatively, 1.5% of Kiora Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Which has more volatility & risk, GRTX or KPRX? Galera Therapeutics has a beta of 1.83, indicating that its share price is 83% more volatile than the S&P 500. Comparatively, Kiora Pharmaceuticals has a beta of -0.5, indicating that its share price is 150% less volatile than the S&P 500. Do analysts recommend GRTX or KPRX? Kiora Pharmaceuticals has a consensus price target of $10.00, indicating a potential upside of 158.40%. Given Kiora Pharmaceuticals' stronger consensus rating and higher probable upside, analysts clearly believe Kiora Pharmaceuticals is more favorable than Galera Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Galera Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Kiora Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Is GRTX or KPRX more profitable? Kiora Pharmaceuticals' return on equity of 21.32% beat Galera Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Galera TherapeuticsN/A N/A -99.34% Kiora Pharmaceuticals N/A 21.32%16.39% Does the media refer more to GRTX or KPRX? In the previous week, Galera Therapeutics' average media sentiment score of 0.00 equaled Kiora Pharmaceuticals'average media sentiment score. Company Overall Sentiment Galera Therapeutics Neutral Kiora Pharmaceuticals Neutral SummaryKiora Pharmaceuticals beats Galera Therapeutics on 9 of the 12 factors compared between the two stocks. Get Galera Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for GRTX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRTX vs. The Competition Export to ExcelMetricGalera TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.40M$6.55B$5.40B$9.24BDividend YieldN/A2.96%5.37%3.99%P/E Ratio-0.139.9389.1417.52Price / SalesN/A335.641,226.4979.25Price / CashN/A64.1243.6036.96Price / Book-0.025.105.014.72Net Income-$59.08M$154.90M$117.89M$224.61M7 Day PerformanceN/A1.58%1.91%1.54%1 Month PerformanceN/A1.75%3.89%5.12%1 Year PerformanceN/A4.64%26.59%21.25% Galera Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRTXGalera TherapeuticsN/A$0.04-7.2%N/A-72.9%$2.40MN/A-0.1330Gap DownKPRXKiora Pharmaceuticals3.2188 of 5 stars$3.41-3.1%$10.00+193.3%-18.8%$10.23M$16M0.0010Gap UpBCDABioCardia3.5063 of 5 stars$2.23+4.6%$25.00+1,022.1%-66.7%$10.21M$71,000.00-0.5340Positive NewsGap DownPHIOPhio Pharmaceuticals2.4668 of 5 stars$6.60+290.5%$36.00+445.5%-59.2%$9.85MN/A-0.6010News CoverageGap UpHigh Trading VolumeTLPHTalphera3.4037 of 5 stars$0.58-4.0%$4.50+681.0%-28.4%$9.81M$281,000.00-0.8419Analyst ForecastNews CoverageINDPIndaptus Therapeutics3.1998 of 5 stars$0.950.0%$8.50+794.9%-51.0%$9.69MN/A-0.566CDTConduit PharmaceuticalsN/A$0.09-24.4%N/A-97.6%$9.59MN/A0.003News CoverageGap UpENSCEnsysce Biosciences0.0151 of 5 stars$7.17-4.3%N/A-53.2%$9.36M$2.23M-0.2610News CoverageGap UpMYNZMainz Biomed2.2838 of 5 stars$4.67+9.1%$120.00+2,469.6%-88.7%$9.35M$917,203.00-0.0730News CoveragePositive NewsGap UpSPRCSciSparc0.4788 of 5 stars$0.85+4.9%N/A-83.8%$8.85M$1.75M0.004Gap UpBFRIBiofrontera3.1385 of 5 stars$1.13+0.9%$7.00+519.5%-37.8%$8.76M$35.36M-0.5070News CoveragePositive News Related Companies and Tools Related Companies KPRX Competitors BCDA Competitors PHIO Competitors TLPH Competitors INDP Competitors CDT Competitors ENSC Competitors MYNZ Competitors SPRC Competitors BFRI Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GRTX) was last updated on 1/22/2025 by MarketBeat.com Staff From Our PartnersBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredDid You See Trump’s Manhattan Project Bombshell?This secret document contains stunning details about Donald Trump’s very first order of business… the minute h...Banyan Hill Publishing | SponsoredKamala’s final humiliation Now, for the first time, I’m going to share these ten investments publicly – the same ones I’ve discussed behi...Porter & Company | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredElon’s #1 AI Stock” SET TO SOARForget ChatGPT! Because Elon Musk's AI promises to be 100x more powerful.Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredTrump Insider: Day One will Shock EveryoneA rare opportunity for everyday Americans like you to turn a small stake into real wealth in the stock market....InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Galera Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Galera Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GRTX Stock Alerts